[Lytic effect of dihydroergotamine Sandoz and hydergine demonstrated by hysterosalpingography].
D000818:Animals; D002317:Cardiovascular Agents; D004087:Dihydroergotamine; D004877:Ergoloid Mesylates; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D005184:Fallopian Tube Diseases; D005187:Fallopian Tubes; D005260:Female; D006801:Humans; D007047:Hysterosalpingography; D010120:Oxytocics
D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D010120:Oxytocics; D004087:Dihydroergotamine; D004877:Ergoloid Mesylates
ERGOT ALKALOIDS/therapeutic use; FALLOPIAN TUBES/diseases
Lytische Wirkung des Dihydroergotamin Sandoz und Hydergin bei der Hysterosalpingographie.